![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 14, 2015 9:15:42 AM
http://content.stockpr.com/aolsrx/media/04530e34d78653e8343cea2f2058258e.pdf
Response to FDA Clinical Hold Q1 2015
Full Data from NHP Study Q1 2015
Orphan Drug Filing - Lung Fibrosis Q1 2015
File IND for Radiation Oncology Q1 2015
Fast Track Filing for Lung-ARS Q1 2015
Lung-ARS Duration of Treatment and Treatment Window Studies Q1 2015
Meet with FDA Respiratory Division to Discuss IPF IND Q1 2015
Chlorine Gas Data Q1 2015
Initiate Phase I in Oncology Q2 2015
Email: sheepery@gmail.com
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM